ENSC

Ensysce Biosciences, Inc.

OTC · Pharmaceutical Preparations · Inc. DE · CIK 0001716947
$0.2541 -14.73% $4.4M
Vol
Market Cap$4.4M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$33.8K
Inst. Activity1 buys / 1 sells
Exchange OTC·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001716947·Prev Close $0.2980

Recent Activity

Inst.
BANK OF AMERICA CORP — DOUBLED
72 shares ($66.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — EXIT
0 shares ($0.00)
Jun 4, 2026 short_volume
Short Volume: ENSC — 58.5% short (1.0M / 1.8M)
Short: 1,038,507 | Exempt: 4,851 | TRF Vol: 1,774,316 | Short Ratio: 58.5% | Off-exchange volume (da

Price Targets

Historical data — last covering-analyst action Sep 2023. No current recommendation available.
$16.45 (Sep 2023)
Current $0.2541 Low $16.45 Median $16.45 High $16.45 1 analysts
$16.45 $16.45

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Sep 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Sep 25, 2023 HC Wainwright & Co. MAINTAIN Buy → Buy
Jul 3, 2023 HC Wainwright & Co. INITIATE Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.50 ▲ +29.6% $-0.50 — $-0.50 37% YoY 1
Next Q $-0.49 ▲ +29.0% $-0.49 — $-0.49 62% YoY 1
Current FY $-1.98 ▲ +44.1% $-1.98 — $-1.98 50% YoY 1
Next FY $-0.11 ▲ +45.0% $-0.11 — $-0.11 94% YoY 1

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$33.8KNEW
BANK OF AMERICA CORP$66.00DOUBLED
2 institutional holders with $33.8K total value (36,780 shares) as of 2025-Q4. Top holders: VANGUARD, BANK.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC36,708$33.8K99.8%NEW
2BANK OF AMERICA CORP /DE/72$66.000.2%DOUBLED +200.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/DOUBLED2472+200.0%$66.002025-Q4
RENAISSANCE TECHNOLOGIES LLCEXIT15,5740-100.0%$0.002025-Q4
VANGUARD GROUP INCNEW36,708$87.0K2025-Q3
RENAISSANCE TECHNOLOGIES LLCNEW15,574$36.9K2025-Q3
UBS Group AGDOUBLED354800+126.0%$1.9K2025-Q3
BANK OF AMERICA CORP /DE/ADD1924+26.3%$57.002025-Q3
UBS Group AGTRIM1,308354-72.9%$789.002025-Q2
BANK OF AMERICA CORP /DE/DOUBLED819+137.5%$42.002025-Q2
UBS Group AGDOUBLED5951,308+119.8%$3.3K2025-Q1

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Sep 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Sep 2023. No current recommendation available.
$16.45 mean target (Sep 2023)
$16.45 Low $16.45 High
MetricValue
Current Price$0.2541
Target Low$16.45
Target Mean$16.45
Target Median$16.45
Target High$16.45
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.50 $-0.50 $-0.50 36.7% +29.6% 1↑ 0↓ $0.0B 38.5% 1
Next Q
2026-09-30
$-0.49 $-0.49 $-0.49 62.0% +29.0% 1↑ 0↓ $0.0B 285.3% 1
Current FY
2026-12-31
$-1.98 $-1.98 $-1.98 50.2% +44.1% 1↑ 0↓ $0.0B 34.2% 1
Next FY
2027-12-31
$-0.11 $-0.11 $-0.11 94.4% +45.0% 1↑ 0↓ $0.0B 1

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.500
7d ago$-0.710+0.210
30d ago$-0.710+0.210
60d ago$0.000-0.500
90d ago$0.000-0.500
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Sep 25, 2023 HC Wainwright & Co. MAINTAIN Buy Buy
Jul 3, 2023 HC Wainwright & Co. INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jul 1, 20242410086%
Jun 1, 20242410086%
May 1, 20242410086%
Apr 1, 20242410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 4, 2026
short_volume
Short Volume: ENSC — 58.5% short (1.0M / 1.8M)
Short: 1,038,507 | Exempt: 4,851 | TRF Vol: 1,774,316 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: ENSC — 55.3% short (0.4M / 0.6M)
Short: 350,062 | Exempt: 41,250 | TRF Vol: 633,333 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
ENSC Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
earnings_calendar
ENSC Q1 2026 Earnings Scheduled — 2026-05-11
May 11, 2026
short_volume
Short Volume: ENSC — 57.8% short (5.4M / 9.3M)
Short: 5,401,752 | Exempt: 607,409 | TRF Vol: 9,341,366 | Short Ratio: 57.8% | Off-exchange volume (dark pool + OTC)
Mar 9, 2026
earnings_calendar
ENSC Q4 2025 Earnings After Market Close — 2026-03-09
Mar 2, 2026
short_interest
FTD: ENSC — 912,968 shares ($0.6M) failed to deliver
Settlement: 20260302, Price: $0.62, FTD Value: $566,040.16, ENSYSCE BIOSCIENCES INC COM PA